Membrane transporters in drug development and as determinants of precision medicine

Aleksandra Galetin*, Kim L.R. Brouwer, Donald Tweedie, Kenta Yoshida, Noora Sjöstedt, Lauren Aleksunes, Xiaoyan Chu, Raymond Evers, Michael J. Hafey, Yurong Lai, Pär Matsson, Andrew Riselli, Hong Shen, Alex Sparreboom, Manthena V.S. Varma, Jia Yang, Xinning Yang, Sook Wah Yee, Maciej J. Zamek-Gliszczynski, Lei ZhangKathleen M. Giacomini*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

The effect of membrane transporters on drug disposition, efficacy and safety is now well recognized. Since the initial publication from the International Transporter Consortium, significant progress has been made in understanding the roles and functions of transporters, as well as in the development of tools and models to assess and predict transporter-mediated activity, toxicity and drug–drug interactions (DDIs). Notable advances include an increased understanding of the effects of intrinsic and extrinsic factors on transporter activity, the application of physiologically based pharmacokinetic modelling in predicting transporter-mediated drug disposition, the identification of endogenous biomarkers to assess transporter-mediated DDIs and the determination of the cryogenic electron microscopy structures of SLC and ABC transporters. This article provides an overview of these key developments, highlighting unanswered questions, regulatory considerations and future directions.

Original languageEnglish
Pages (from-to)255-280
Number of pages26
JournalNature Reviews Drug Discovery
Volume23
Issue number4
Early online date24 Jan 2024
DOIs
Publication statusPublished - 1 Apr 2024

Fingerprint

Dive into the research topics of 'Membrane transporters in drug development and as determinants of precision medicine'. Together they form a unique fingerprint.

Cite this